13F

Stock

Galmed Pharmaceuticals Ltd.

GLMD · held by 17 managers

Reported value

$166.4K

Holders

17

+0 new · −0 exited

Holders’ est. mark

−$62

Price effect on 2 books still in the name

Largest holder

$84.2K

TWO SIGMA INVESTMENTS, LP

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
TWO SIGMA INVESTMENTS, LP112.1K$84.2KHeld
Citadel38.2K$28.7KHeld
TWO SIGMA ADVISERS, LP31.5K$23.6KHeld
TWO SIGMA SECURITIES, LLC13.6K$10.2KHeld
JANE STREET GROUP, LLC12.1K$9.11KHeld
XTX Topco Ltd11K$8.29KHeld
UBS Group AG1.81K$1.36KHeld
BNP PARIBAS FINANCIAL MARKETS900$675Held
MORGAN STANLEY298$224−$61Added$89
SBI Securities Co., Ltd.16$12Held
Federation des caisses Desjardins du Quebec14$11Held
WELLS FARGO & COMPANY/MN9$7Held
OSAIC HOLDINGS, INC.5$3Held
Allworth Financial LP2$2−$1Cut−$1
ELEVATION WEALTH PARTNERS, LLC1$1Held
Dogwood Wealth Management LLC1$1Held
TSFG, LLC17$0Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.